Literature DB >> 31081402

Bacteriophage Therapy of Chronic Nonhealing Wound: Clinical Study.

Pooja Gupta1, Hari Shankar Singh2, Vijay K Shukla2, Gopal Nath1, Satyanam Kumar Bhartiya2.   

Abstract

BACKGROUND: A chronic wound usually results due to halt in the inflammatory phase of wound healing. Bacterial infections and biofilm formation are considered to be the basic cause of it. Chronic wounds significantly impair the quality of life. Antibiotics are now failing due to biofilm formation emergence of drug-resistant bacteria.
OBJECTIVE: This study aims to see the effect of bacteriophage therapy in chronic nonhealing wound infected with the following bacteria: Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. SUBJECT: Patients with chronic nonhealing wound not responding to conventional local debridement and antibiotic therapy were included in the study. The age of patients ranged between 12 and 60 years.
METHOD: A total of 20 patients selected and tissue biopsies and wound swabs were taken for isolation of the bacteria. After confirmation of organism, a cocktail of customized bacteriophages was topically applied over the wound on alternate days till the wound surface became microbiologically sterile. Mean bacterial count and clinical assessment were done and compared at the time of presentation and after 3 and 5 doses of application.
RESULTS: A significant improvement was observed in the wound healing, and there were no signs of infection clinically and microbiologically after 3 to 5 doses of topical bacteriophage therapy. Seven patients achieved complete healing on day21 during follow up while in others healthy margins and healthy granulation tissue were observed.
CONCLUSION: Topical bacteriophage application may be quite effective therapy for the treatment of chronic nonhealing wounds.

Entities:  

Keywords:  antibiotic resistance; chronic wound; microbial infection; topical bacteriophage therapy

Mesh:

Year:  2019        PMID: 31081402     DOI: 10.1177/1534734619835115

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  21 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 2.  The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.

Authors:  Angharad Steele; Helen J Stacey; Steven de Soir; Joshua D Jones
Journal:  Antibiotics (Basel)       Date:  2020-10-29

Review 3.  The phages of staphylococci: critical catalysts in health and disease.

Authors:  Asma Hatoum-Aslan
Journal:  Trends Microbiol       Date:  2021-05-21       Impact factor: 17.079

4.  BeQuIK (Biosensor Engineered Quorum Induced Killing): designer bacteria for destroying recalcitrant biofilms.

Authors:  Pinpunya Riangrungroj; Karen M Polizzi
Journal:  Microb Biotechnol       Date:  2019-07-21       Impact factor: 5.813

Review 5.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11

Review 6.  Bacteriophage Therapy of Bacterial Infections: The Rediscovered Frontier.

Authors:  Nejat Düzgüneş; Melike Sessevmez; Metin Yildirim
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-05

7.  Patient perceptions of phage therapy for diabetic foot infection.

Authors:  Katherine E Macdonald; Helen J Stacey; Gillian Harkin; Lesley M L Hall; Matthew J Young; Joshua D Jones
Journal:  PLoS One       Date:  2020-12-14       Impact factor: 3.240

Review 8.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

9.  Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis.

Authors:  Jonathan Save; Yok-Ai Que; José M Entenza; Camille Kolenda; Frédéric Laurent; Grégory Resch
Journal:  J Am Heart Assoc       Date:  2022-01-19       Impact factor: 6.106

Review 10.  Bacteriophages for Chronic Wound Treatment: from Traditional to Novel Delivery Systems.

Authors:  Ana M Pinto; Miguel A Cerqueira; Manuel Bañobre-Lópes; Lorenzo M Pastrana; Sanna Sillankorva
Journal:  Viruses       Date:  2020-02-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.